Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue

Logo poskytovatele

Varování

Publikace nespadá pod Ústav výpočetní techniky, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

BOSÁKOVÁ Veronika PAPATHEODOROU Ioanna KAFKA Filip TOMÁŠIKOVÁ Zuzana KOLOVOS Petros HORTOVÁ KOHOUTKOVÁ Marcela FRIČ Jan

Rok publikování 2025
Druh Článek v odborném periodiku
Časopis / Zdroj EXPERIMENTAL AND MOLECULAR MEDICINE
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.nature.com/articles/s12276-025-01397-1
Doi http://dx.doi.org/10.1038/s12276-025-01397-1
Klíčová slova tumor necrosis; human mucosal tissue; intestinal inflammation
Přiložené soubory
Popis The intestine hosts the largest immune system and peripheral nervous system in the human body. The gut-brain axis orchestrates communication between the central and enteric nervous systems, playing a pivotal role in regulating overall body function and intestinal homeostasis. Here, using a human three-dimensional in vitro culture model, we investigated the effects of serotonin, a neuromodulator produced in the gut, on immune cell and intestinal tissue interactions. Serotonin attenuated the tumor necrosis factor-induced proinflammatory response, mostly by affecting the expression of chemokines. Serotonin affected the phenotype and distribution of tissue-migrating monocytes, without direct contact with the cells, by remodeling the intestinal tissue. Collectively, our results show that serotonin plays a crucial role in communication among gut-brain axis components and regulates monocyte migration and plasticity, thereby contributing to gut homeostasis and the progression of inflammation. In vivo studies focused on the role of neuromodulators in gut inflammation have shown controversial results, highlighting the importance of human experimental models. Moreover, our results emphasize the importance of human health research in human cell-based models and suggest that the serotonin signaling pathway is a new therapeutic target for inflammatory bowel disease.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info